Tag: MHRA

Orphan Designation for Silence’s β-Thalassemia Drug

Silence Therapeutics’ lead candidate SLN124 has secured orphan drug designation in the European Union for the treatment of β-Thalassemia. The designation to SLN124 was granted by the Committee for ...

MHRA Approved Upperton New Facilities

Spray drying specialist has invested in building enhancements and in the expansion of its processing and analytical capabilities The UK Medicines and Healthcare products Regulatory Agency (MHRA) ha...

Men in UK Sentenced for Illegal Supply of Meds

Three people have been handed custodial sentences in England for their involvement in the illegal supply of potentially dangerous prescription-only medicines. Jagdiep Dhonsi, Amrin Mirza and Shirin...

Risk for Pharma after Brexit still Unknown

A ‘no deal’ Brexit will change and burden how all industries that move materials and goods across borders, including the pharmaceutical and medical device sectors, do business. Pharmaceutical compa...

UK MHRA clarified cross-contamination Control Requirements

With the introduction of the Permitted Daily Exposure (PDE) values in conjunction with questions on cross contamination and on cleaning validation, the EMA began a new chapter a few years ago. This is...